Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail B Cross

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2019
Emergence of Attenuated Measles Illness Among IgG-positive/IgM-negative Measles Cases: Victoria, Australia, 2008-2017Katherine B Gibney, Lucy O Attwood, Suellen Nicholson, et al.
BMC Infectious Diseases|February 22, 2014
TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective studyGail B Cross, Katie Coles, Mandana Nikpour, et al.
Nature Communications|December 2, 2024
PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatmentGail B Cross, Intan P Sari, Sarah M Burkill, et al.
The Lancet. Infectious Diseases|March 26, 2023
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trialGail B Cross, Intan P Sari, Cissy Kityo, et al.
BMC Medical Genomics|June 12, 2021
A blood RNA transcriptome signature for COVID-19Philip Kam Weng Kwan, Gail B Cross, Claire M Naftalin, et al.
The Journal of Infectious Diseases|March 25, 2024
Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation TrialNicholas I Paton, Meera Gurumurthy, Qingshu Lu, et al.
Journal of Medical Virology|February 16, 2022
Discrepant serological findings in SARS-CoV-2 PCR-negative hospitalized patients with fever and acute respiratory symptoms during the pandemicGail B Cross, Claire M Naftalin, Jinghao N Ngiam, et al.
Infectious Diseases and Therapy|January 12, 2021
Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 TestingJoshua K Tay, Gail B Cross, Louisa Sun, et al.
Journal of Thrombosis and Thrombolysis|July 15, 2020
Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in SingaporePrakash R Paliwal, Benjamin Y Q Tan, Aloysius S T Leow, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 18, 2021
Design and Multicenter Clinical Validation of a 3-Dimensionally Printed Nasopharyngeal Swab for SARS-CoV-2 TestingJoshua K Tay, Gail B Cross, Song Tar Toh, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2019
Emergence of Attenuated Measles Illness Among IgG-positive/IgM-negative Measles Cases: Victoria, Australia, 2008-2017Katherine B Gibney, Lucy O Attwood, Suellen Nicholson, et al.
BMC Infectious Diseases|February 22, 2014
TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective studyGail B Cross, Katie Coles, Mandana Nikpour, et al.
Nature Communications|December 2, 2024
PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatmentGail B Cross, Intan P Sari, Sarah M Burkill, et al.
The Lancet. Infectious Diseases|March 26, 2023
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trialGail B Cross, Intan P Sari, Cissy Kityo, et al.
BMC Medical Genomics|June 12, 2021
A blood RNA transcriptome signature for COVID-19Philip Kam Weng Kwan, Gail B Cross, Claire M Naftalin, et al.
The Journal of Infectious Diseases|March 25, 2024
Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation TrialNicholas I Paton, Meera Gurumurthy, Qingshu Lu, et al.
Journal of Medical Virology|February 16, 2022
Discrepant serological findings in SARS-CoV-2 PCR-negative hospitalized patients with fever and acute respiratory symptoms during the pandemicGail B Cross, Claire M Naftalin, Jinghao N Ngiam, et al.
Infectious Diseases and Therapy|January 12, 2021
Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 TestingJoshua K Tay, Gail B Cross, Louisa Sun, et al.
Journal of Thrombosis and Thrombolysis|July 15, 2020
Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in SingaporePrakash R Paliwal, Benjamin Y Q Tan, Aloysius S T Leow, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 18, 2021
Design and Multicenter Clinical Validation of a 3-Dimensionally Printed Nasopharyngeal Swab for SARS-CoV-2 TestingJoshua K Tay, Gail B Cross, Song Tar Toh, et al.
Pageof 2